Related Experiment Video
Updated: Oct 12, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Inhalational Anesthesia for Near-fatal Pediatric Asthma Complicated by Malignant Hyperthermia
Davij Pasrija1, Justin Assioun2, Mohammad Sallam1
1Department of Pediatric Critical Care, University at Buffalo, Buffalo, USA.
Insights
Severe pediatric asthma requires advanced treatments like mechanical ventilation and, rarely, inhaled anesthetics. A rare side effect of these anesthetics, malignant hyperthermia, has not been documented in pediatric intensive care units for asthma cases.
Area of Science:
- Pediatric Critical Care Medicine
- Respiratory Medicine
- Anesthesiology
Background:
- Acute severe asthma is a frequent pediatric emergency requiring bronchodilators, steroids, and mechanical ventilation.
- Refractory cases may necessitate inhaled anesthetics or extracorporeal gas exchange (ECMO).
- Inhaled anesthetic use in pediatric intensive care units (PICUs) for asthma is uncommon and resource-dependent.
Observation:
- Common side effects of inhaled anesthetics include hypotension, arrhythmias, and delirium.
- Malignant hyperthermia (MH) is a known, albeit rare, complication of inhaled anesthetics and depolarizing muscle agents.
- MH has not been previously reported in the PICU setting following anesthetic use for pediatric asthma exacerbations.
Findings:
- This abstract highlights the infrequent use and potential side effects of inhaled anesthetics in pediatric severe asthma management.
- It specifically notes the absence of reported malignant hyperthermia cases in this context.
- Treatment protocols for severe pediatric asthma vary by institution.
Implications:
- Further investigation into the safety profile of inhaled anesthetics for pediatric asthma is warranted.
- Clinicians should be aware of potential side effects, including the theoretical risk of MH.
- Standardized guidelines for managing refractory severe pediatric asthma may improve patient outcomes.
Abstract:
Acute severe asthma is a commonly encountered condition in the pediatric emergency room and the pediatric intensive care unit (PICU). Its treatment involves the use of bronchodilatory agents acting on different receptors, steroids to reduce ongoing inflammation, and non-invasive or invasive mechanical ventilation to offload the increased work of breathing from the respiratory muscles. Patients refractory to these therapies may require the use of inhaled anesthetic agents and extracorporeal gas exchange (ECMO) for life-threatening asthma exacerbations. Depending on institutional protocols, the use of these therapies may vary. The use of inhaled anesthetic agents for asthma management in the PICU is infrequent and is limited to centers with specialized equipment. Commonly encountered side effects include hypotension, arrhythmias, and delirium. Malignant hyperthermia (MH) is a well-known but infrequent side effect of inhaled anesthetic use, depolarizing muscle agents, and has not been described in the PICU following the use of anesthetics for pediatric asthma.
More Related Videos
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
04:56In Vitro Method to Control Concentrations of Halogenated Gases in Cultured Alveolar Epithelial Cells
Published on: October 23, 2018
Related Concept Videos
Inhalational Anesthetics: Overview
Parenteral Anesthetics: Overview
Skeletal Muscle Relaxants: Therapeutic Uses
Acute Respiratory Failure-III
Cardiopulmonary Resuscitation II: ACLS Airway Management
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...